Thymosin alpha 1
Brief Introduction:
Thymosin alpha 1, also called Thymosin α1 or Thymalfasin, which is an active ingredient in thymosin immunomodulatory drugs, it is often used to enhance immune function or assist in the treatment of certain infectious diseases (such as chronic hepatitis B, immunodeficiency, etc.).
Sequence:
Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
Mechanism of Action:
Thymosin alpha 1 mainly exerts its therapeutic effect by enhancing the body's immunity. It can promote the differentiation, maturation and activation of T lymphocytes, enhance the body's immunity, and thus fight against tumors, viruses and other pathogens.
In addition, Thymosin alpha 1 can also inhibit the proliferation and spread of tumor cells, as well as regulate the body's immune response and improve the immune function of tumor patients.
Indications:
▲ For Patients with Chronic Hepatitis B Aged 18 Years or Older:
Thymalfasin treatment can produce viral remission (loss of serum HBV-DNA) and normalization of transaminase levels; in some responding patients, thymalfasin treatment can eliminate serum surface antigen.
▲ As a Vaccine Booster for Immunocompromised Individuals:
For individuals with suppressed immune systems, including those on chronic hemodialysis and the elderly, Thymosin α1 can enhance the immune response to viral vaccines, such as influenza vaccine or hepatitis B vaccine.
▲ Adjuvant Therapy for Anti-Tumor:
Enhance the immune system function of patients with malignant tumors, by enhancing the antigen expression of tumor cells, tumor cells are more easily recognized and killed by immune cells, achieving adjuvant therapy and combating tumor metastasis; it can also improve the body's immunity, accelerate the recovery of immune function, improve immunosuppression, organ damage and other side effects produced during anti-tumor treatment, and improve the quality of life.
Specifications of our Thymalfasin (Thymosin α1):
| Test Items | Specifications |
| Appearance | White powder |
| MS (ESI) | Conforms |
| Purity (HPLC) | Not less than 98.0% |
| Water Content (Karl Fischer) | Not more than 10.0% |
| Peptide Content (N%) | Not less than 80.0% |
| Mass Balance | 95.0% ~ 105.0% |
Usage & Dosage:
Dissolve Thymalfasin (1.6 mg) in 1 ml of water for injection and inject subcutaneously immediately.
Packaging:
① Raw Powder: 1g/Bottle, 2g/Bottle, 3g/Bottle, 5g/Bottle or according to the specific requirements from customers.
② Lyophilized Powder: 10 Vials per Box (2mg/Vial, 5mg/Vial or 10mg/Vial).
Minimum Order Quantity (MOQ):
① Raw Powder: 1 gram.
② Lyophilized Powder: One Box (2mg*10vials, 5mg*10vials or 10mg*10vials).
Payment Methods:
Modes of Transport:
Storage Conditions:
① Raw Powder:
Stored in a cool dry place away from sunlight and moisture (Recommended temperature: below -20℃).
② Lyophilized Powder:
Preserved in air tight containers, protected from light (Recommended temperature: -25℃ ~ -15℃).
Shelf Life:
24 months from the date of manufacturing when stored under the above mentioned conditions.
